Pfizer DMD drug domagrozumab fails in two clinical trials
Pfizer DMD drug update : US pharma giant Pfizer will scrap a couple of ongoing clinical trials evaluating its humanized
Continue readingCoverage of Global Pharma Industry News
Pfizer DMD drug update : US pharma giant Pfizer will scrap a couple of ongoing clinical trials evaluating its humanized
Continue readingThe European Commission (EC) has approved an expanded indication for Amgen blood cancer drug BLINCYTO (blinatumomab) as monotherapy for the
Continue readingUrovant Sciences has acquired global licensing rights for the development and commercialization of a gene therapy called hMaxi-K from Ion
Continue readingJanssen Pharmaceutical has bagged approval from the US Food and Drug Administration (FDA) for its combo of IMBRUVICA (ibrutinib) and
Continue readingCantex Pharmaceuticals, a Florida-based biotech company, has secured the fast track designation for its acute myeloid leukemia drug CX-01 from
Continue readingLEO Pharma, a Danish pharma company, has bagged global exclusive rights for atopic dermatitis drug JW1601 from JW Pharmaceutical (JWP)
Continue readingSwiss drugmaker Novartis unveiled new data on Entresto (sacubitril/valsartan) from a phase 4 study which confirms that the heart failure
Continue readingUS biopharma company PTC Therapeutics has completed its $200 million acquisition of Agilis Biotherapeutics, a biotechnology company engaged in the
Continue readingAltreno FDA approval : Ortho Dermatologics, a division of Bausch Health Companies, has bagged approval from the US Food and
Continue readingOxervate FDA approval : Italian pharma company Dompé farmaceutici has bagged an approval for Oxervate (cenegermin) eye drops from the
Continue reading